Liquidity Events
Carlyle Group sells 4.3% in healthcare tech co. Indegene for Rs.636-Cr
Carlyle Group (through its affiliate CA Dawn Investments) has divested a 4.3% stake (1,02,63,785 shares) in publicly-listed Bengaluru-based healthcare-tech firm Indegene for INR 636 crore through an open market transaction.The shares were offloaded at an average price of INR 619.82 apiece, taking the transaction value to INR 636.17 crore. Post-sale, Carlyle's holding in Indegene has come down to 10.22% from 14.52%.
Between Jan 2021 and Mar 2023, Indegene had raised about USD 206.5 M from Avendus PE, Brighton Park Capital and Carlyle.For FY24, Indegene had reported about INR 2,589.60 Cr in Operating Income and about INR 336.70 Cr in PAT.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
